The 1 analysts offering 12-month price forecasts for BiondVax Pharmaceuticals Ltd have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +831.68% increase from the last price of 3.22.
The current consensus among 1 polled investment analysts is to Buy stock in BiondVax Pharmaceuticals Ltd. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.01
Reporting Date Nov 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.